Genetic Counseling in Direct-to-Consumer Exome Sequencing: A Case Report

Journal of Genetic Counseling

Volumn 23, Issue 5, 2014, Pages 742-753

  van den Berg, Saskia ^a,b   Shen, Yaoqing ^c   Jones, Steven J M ^c   Gibson, William T ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; COMMUNITY PARTICIPATION; EXOME; FEMALE; GENETIC COUNSELING; HUMAN; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; COMMUNITY PARTICIPATION; EXOME; FEMALE; GENETIC COUNSELING; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS;

EID: 84929992792     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-014-9737-0     Document Type: Article

References (35)

1. Ackerman, M. J., Tester, D. J., Jones, G. S., Will, M. L., Burrow, C. R., & Curran, M. E. (2003). Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital Long QT syndrome. Mayo Clinic Proceedings, 78, 1479–1487.
2. American College of Medical Genetics and Genomics. (2013). Incidental findings in clinical genomics: a clarification. Genetics in Medicine, 15, 664–666.
3. Annas, G. J., & Elias, S. (2014). 23andMe and the FDA. New England Journal of Medicine, 370, 985–988.
4. Brett, G. R., Metcalfe, S. A., Amor, D. J., & Halliday, J. L. (2012). An exploration of genetic health professionals’ experience with direct-to-consumer genetic testing in their clinical practice. European Journal of Human Genetics, 20, 825–830.
5. Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., et al. (2009). Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proceedings of the National Academy of Sciences of the United States of America, 106, 19096–19101.
6. Deladoey, J., Fluck, C., Bex, M., Yoshimura, N., Harada, N., & Mullis, P. E. (1999). Aromatase deficiency caused by a novel P450 gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy. Journal of Clinical Endocrinology and Metabolism, 84, 4050–4054.
7. Dewey, F. E., Grove, M. E., Pan, C., Goldstein, B. A., Bernstein, J. A., Chaib, H., et al. (2014). Clinical interpretation and implications of whole-genome sequencing. Journal of the American Medical Association, 331, 1035–1045.
8. Dorschner, M. O., Amendola, L. M., Turner, E. H., Robertson, P. D., Shirts, B. H., Gallego, C. J., et al. (2013). Actionable, pathogenic incidental findings in 1,000 participants’ exomes. American Journal of Human Genetics, 93, 631–640.
9. Egglestone, C., Morris, A., & O’Brien, A. (2013). Effect of direct-to-consumer genetic tests on health behavior and anxiety: a survey of consumers and potential consumers. Journal of Genetic Counseling, 22, 565–575.
10. Fokkema, I. F., den Dunnen, J. T., & Taschner, P. E. (2005). LOVD: easy creation of a locus-specific sequence variation database using an “LSDB-in-a-box” approach. Human Mutation, 26, 63–68.
11. Genest, J., McPherson, R., & Frohlich, J. (2009). Canadian Cancer Society/Canadian Guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult- 2009 recommendations. Canadian Journal of Cardiology, 10, 567–579.
12. Gollust, S. E., Gordon, E. S., Zayac, C., Griffin, G., Christmas, M. F., Pyeritz, R. E., et al. (2012). Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics, 15, 22–30.
13. Green, R. C., Berg, J. S., Wayne, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., et al. (2013). ACMG Recommendations for reporting of incidental findings in Clinical exome and genome sequencing. Genetics in Medicine, 15, 565–574.
14. Green, R. C., & Farahany, N. A. (2014). Regulation: the FDA is overcautious on consumer genomics. Nature, 505, 286–287.
15. Gutierrez, A. (2013). United states department of health and human services public health service food and drug administration warning letter CMS 415534 Document Number: GEN1300666 Re: Personal Genome Service (PGS). [Online Letter dated 22 Nov 2013]. Retrieved from http://www.fda.gov/iceci/enforcementactions/warningletters/2013/ucm376296.htm.
16. Gutierrez, A. (2014). United states department of health and human services public health service food and drug administration close out letter Re: Personal Genome Service (PGS). [Online Letter dated 25 Mar 2014]. Retrieved from http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm391016.htm.
17. Harris, A., Kelly, S. E., & Wyatt, S. (2013). Counseling customers: emerging roles for genetic counselors in the Direct-to-consumer genetic testing market. Journal of Genetic Counseling, 22, 277–288.
18. Howard, H. C., & Borry, P. (2013). Survey of European clinical geneticists on awareness, experiences and attitudes towards direct-to-consumer genetic testing. Genome Medicine, 5, 45–56.
19. Kalf, R. R., Mihaescu, R., Kundu, S., de Knijff, P., Green, R. C., & Janssens, A. C. (2014). Variations in predicted risks in personal genome testing for common complex diseases. Genetics in Medicine, 16, 85–91.
20. Lafranco, F., Zirilli, L., Baldi, M., Pignatti, E., Corneli, G., Ghigo, E., et al. (2008). A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Bone, 43, 628–635.
21. Lin, L., Ercan, O., Raza, J., Burren, C. P., Creighton, S. M., Auchus, R. J., et al. (2007). Variable phenotypes associated with aromatase (CYP19) insufficiency in humans. Journal of Clinical Endocrinology and Metabolism, 92, 982–990.
22. Lohn, Z., Adam, S., Birch, P. H., & Friedman, J. M. (2013). Incidental findings for clinical genome-wide sequencing: a review. Journal of Genetic Counseling. doi:10.1007/s10897-013-9604-4. Advance online publication.
23. MacArthur, D. G., Manolio, T. A., Dimmock, D. P., Rehm, H. L., Shendure, J., Abecasis, G. R., et al. (2014). Guidelines for investigating causality of sequence variants in human disease. Nature, 508, 469–476.
24. McBride, C. M., Alford, S. H., Reid, R. J., Larson, E. B., Baxevanis, A. D., & Brody, L. C. (2009). Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genetics in Medicine, 11, 582–587.
25. McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P., et al. (2008). Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Reviews Genetics, 9, 356–369.
26. Miremadi, S., Sniderman, A., & Frohlich, J. (2002). Can measurement of serum Apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders? Clinical Chemistry, 48, 484–488.
27. Ormond, K. E., Wheeler, M. T., Hudgins, L., Klein, T. E., Butte, A. J., Altman, R. B., et al. (2010). Challenges in the clinical application of whole-genome sequencing. Lancet, 375, 1749–1751.
28. Pepe, C. M., Saraco, N. I., Baquedano, M. S., Guercio, G., Vaiani, E., Marino, R., et al. (2007). The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of non-classic aromatase deficiency and is also present in normal human steroidogenic tissues. Clinical Endocrinology, 67, 698–705.
29. Sturm, A. C., & Manickam, K. (2012). Direct-to-consumer personal genomic testing: a case study and practical recommendations for “genomic counseling.”. Journal of Genetic Counseling, 21, 402–412.
30. Wade, C. H., & Wilfond, B. S. (2006). Ethical and clinical practice considerations for genetic counselors related to Direct-to-consumer marketing of genetic tests. American Journal of Medical Genetics Part C, 142C, 284–292.
31. Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998). Prediction of coronary heart disease using risk factor categories. Circulation, 97, 1837–1847.
32. Yang, Y., Muzny, D. M., Reid, J. G., Bainbridge, M. N., Willis, A., Ward, P. A., et al. (2013). Clinical Whole-exome sequencing for the diagnosis of Mendelian disorders. New England Journal of Medicine, 369, 1502–1511.
33. Yu, W., Nohara, A., Higashikata, T., Lu, H., Inazu, A., & Mabuchi, H. (2002). Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional differences of LDL receptor gene mutations in Japanese populations. Atherosclerosis, 165, 335–342.
34. Zirilli, L., Rocira, V., Diazzi, C., Caffagni, G., & Carani, C. (2008). Human models of aromatase deficiency. Journal of Steroid Biochemistry and Molecular Biology, 109, 212–218.
35. 23andMe. Exome 80x Pilot Program (2011). Retrieved from https://www.23andme.com/exome/. Accessed 14Feb2014.